Spironolactone of no benefit in people with AF and HFpEF-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spironolactone of no benefit in people with AF and HFpEF

Published:2021-10-18 Issue:12 Volume:59 Page:181-181
ISSN:0012-6543
Container-title:Drug and Therapeutics Bulletin
language:en
Short-container-title:DTB

Author:

Abstract

AbstractOverview of: Shantsila E, Shahid F, Sun Y, et al. Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT. Efficacy Mech Eval 2020; 7(4).

Publisher

BMJ

Subject

Pharmacology (medical),General Medicine

Reference6 articles.

1. Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT;Shantsila;Efficacy Mech Eval,2020

2. Joint Formulary Committee . British National Formulary - spironloactone, 2021. Available: https://bnf.nice.org.uk/drug/spironolactone.html [Accessed 27 Sep 2021].

3. Spironolactone 25 mg film-coated tablets . Summary of product characteristics, UK. ACCORD healthcare limited, 2018.

4. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

5. Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP